OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis
Fatemeh Karami, Hamidreza Jamaati, Natalie Coleman‐Fuller, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 3, pp. 511-543
Closed Access | Times Cited: 15

Showing 15 citing articles:

Glucose Transport and Utilization in the Hippocampus: From Neurophysiology to Diabetes-Related Development of Dementia
Caio Yogi Yonamine, Maria Luiza Estimo Michalani, Rafael Junges Moreira, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16480-16480
Open Access | Times Cited: 16

Metformin improves cognitive dysfunction through SIRT1/NLRP3 pathway–mediated neuroinflammation in db/db mice
Hu Tian, Jun-Wen Wei, Jiayi Zheng, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 9, pp. 1101-1115
Closed Access | Times Cited: 5

A review on polyamines as promising next-generation neuroprotective and anti-aging therapy
Richmond Arthur, Sumit Jamwal, Puneet Kumar
European Journal of Pharmacology (2024) Vol. 978, pp. 176804-176804
Closed Access | Times Cited: 4

Engineered exosome therapeutics for neurodegenerative diseases
Biplob Saikia, Anandh Dhanushkodi
Life Sciences (2024) Vol. 356, pp. 123019-123019
Open Access | Times Cited: 4

The Potential Role of Mitochondria in the Microbiota-Gut-Brain Axis: Implications for Brain Health
Lei Qiao, Ge Yang, Peng Wang, et al.
Pharmacological Research (2024) Vol. 209, pp. 107434-107434
Open Access | Times Cited: 4

Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders
Laura Mihaela Isop, Andrea Elena Neculau, Radu Necula, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1714-1714
Open Access | Times Cited: 9

Neuroprotective Effects of Metformin on Cerebral Ischemia-Reperfusion Injury: Modulation of JNK and p38 MAP Kinase Signaling Pathways
Shicun Zhang, Wei Zou, Yan Jia Leng, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 2597-2606
Open Access | Times Cited: 3

Exploring the clinical connections between epilepsy and diabetes mellitus: Promising therapeutic strategies utilizing agmatine and metformin
Aayushi Nangia, Janani Srividya Saravanan, Shruti Hazra, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2

Inducing Agents for Alzheimer’s Disease in Animal Models
Karishma Khan, Nasr A. Emad, Yasmin Sultana
Journal of Exploratory Research in Pharmacology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 1

Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review
Mina Gholami, Natalie Coleman‐Fuller, Mahsa Salehirad, et al.
International Journal of Preventive Medicine (2024) Vol. 15
Open Access

Differences in histone modifications between individuals
Milad Shirvaliloo
Elsevier eBooks (2024), pp. 41-70
Closed Access

Page 1

Scroll to top